Innova™ Vascular H74939293061870Recalls & reported problems
Boston Scientific Corporation · Self-Expanding Stent System · Class 3 · Implant
All models of Innova Vascular (42)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729873693), received between Nov 22, 2016 and Jul 12, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
2 other recalls cover devices cleared under the same FDA submission (P140028); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Bent1
- Stretched1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 12, 2017Stretched; Stretched
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE 90% STENOSED TARGET LESION WAS LOCATED IN A MILDLY TORTUOUS AND MODERATELY CALCIFIED SUPERFICIAL FEMORAL ARTERY (SFA). IPSILATERAL ANTEGRADE APPROACH WAS PERFORMED. FOLLOWING PRE-DILATION, A 6X180X75 INNOVA STENT WAS PLACED AND DEPLOYMENT WAS INITIATED VIA THE THUMB WHEEL. DURING DEPLOYMENT THE STENT STRETCHED ABOUT 2CM ON THE PROXIMAL SIDE. THE PHYSICIAN STATES THAT HE FELT TENSION ON THE SHAFT AT THE TIME OF THE EVENT. AFTER DEPLOYING 120MM OF THE STENT, THE DEPLOYMENT STOPPED, THE PHYSICIAN CONTINUED TO TURN THE THUMBWHEEL AND DEPLOYMENT WAS EVENTUALLY ACHIEVED. THE PROCEDURE WAS COMPLETED WITH THIS DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6709032 ↗MalfunctionNov 22, 2016Bent; Activation, Positioning or Separation Problem; Bent; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT THERE WAS PARTIAL DEPLOYMENT AND STENT DAMAGE. A 6 X 180 X 75 INNOVA¿ SELF-EXPANDING STENT WAS SELECTED FOR AN EVT PROCEDURE IN THE MILDLY TORTUOUS 100% STENOSED SUPERFICIAL FEMORAL ARTERY (SFA). AN IPSILATERAL ANTEGRADE APPROACH WAS USED TO ACCESS THE LESION. THE LESION WAS 2 MM PRE-DILATED. THE INNOVA WAS INSERTED BY A NON-BSC GUIDEWIRE, BUT IT WAS NOT ABLE TO CROSS THE LESION. IT WAS ABLE TO CROSS THE LESION AFTER THE GUIDEWIRE WAS CHANGED TO A 0.35. THE STENT WAS DEPLOYED BY THE THUMB WHEEL UP TO 12 CM WITHOUT ANY RESISTANCE. AFTER THAT, IT WAS NOT ABLE TO PERFORM PULL BACK AND DEPLOY COMPLETELY. THE THUMBWHEEL WAS USED WITH NORMAL FORCE UNTIL THE WHITE ARROW WAS VISIBLE. THE PULL GRIP WAS NOT USED. THE HANDLE WAS DISASSEMBLED AND IT WAS FOUND THAT THE STENT WAS STRETCHED AND DEPLOYED IN THE SHEATH. THE STENT WAS ABLE TO BE PUSHED INTO THE TARGET VESSEL. THE PROCEDURE WAS COMPLETED WITH THIS DEVICE. THE STENT DID NOT FRACTURE AND THERE WERE NO KINKS. THERE WERE NO PATIENT COMPLICATIONS AND THE PATIENT STATUS WAS GOOD.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6120195 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P140028. One submission often covers many models, so check the product and lot details in each record.
- Z-0685-2018 · Nov 6, 2017 · Open, ClassifiedInnova Self-Expanding Stent System, 200 mm. Labeled with Material Number and description as follows: Product Usage: The Innova Vascular Self-Expanding Stent System is indicated t
- Z-0686-2018 · Nov 6, 2017 · Open, ClassifiedInnova Self-Expanding Stent System, 180mm. Labeled with Material Number and description as follows: Product Usage: The Innova Vascular Self-Expanding Stent System is indicated
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page